Recognizing the groundbreaking contributions to the science of eye health by Dr. Mark Babizhayev*

*Inventor and patent holder of Can-C™

Dr. Babizhayev: “We started our work on N-acetylcarnosine as a potent ophthalmic drug in 1991”


1992: Dr. Mark Babizhayev receiving the prestigious Oka Memorial Award, Yokohama, Japan


Dr. Mark Babizhayev is a bio-physicist and holds a Ph.D. in Biophysics and Pathophysiology. He has dedicated many years to scientific research, principally at the Helmholtz Research Institute of Eye Disease, in Moscow. During that time, he has accumulated over 86 published articles and also has 15 patents to his name. He is also a principle involved in the development of a breakthrough for the treatment and prevention of senile cataract.

2001 Interview: “The NAC anti-cataract eye drops have been carefully tested in animals. The most striking results have been obtained using a 1% NAC instillation in canines with age-related cataracts.”  …more


2003 Interview: “We have developed a very precise product with N-acetylcarnosine, because only certain types and levels of impurities enable the maintenance of the peculiar antioxidant activities of the released molecule”  …more


Dr. Mark Babizhayev of Innovative Vision Products (IVP), Introduces Wise Choice Medicine as a new supplier of his patented eye drop product for the treatment of cataracts. …more


Sept. 2010– Wise Choice Medicine Hosts Dr Mark Babizhayev.

Click here for
Dr Babizhayev Statement of Fact


Welcome to the shiny new!

Finding the best vision support solutions has never been easier thanks to side-by-side program comparisons and access to the extensive clinical research supporting our products.

For any questions please contact our helpful and knowledgable support team at 1-800.861.4936